Abstract:Every cell is covered with a dense layer of glycans, which is termed glycocalyx. The outermost monosaccharide of these glycans is often sialic acid, which are a family of nine-carbon monosaccharides. Sialylated glycans play important roles in various physiological and pathological processes, including pathogen invasion, cancer progress, and immune response. Lectins and antibodies have long been used for labeling and detecting sialylated glycans. However, they suffer from low affinity and poor specificity. In the past decades, metabolic glycan labeling (MGL) has emerged as a powerful tool for probing sialylation in live cells and living animals. In the MGL strategy, unnatural sugars containing a bioorthogonal functional group is metabolically incorporated into sialylated glycans by exploiting the underlying glycan biosynthetic pathway. Subsequent bioorthogonal reactions enable conjugation of sialylated glycans with imaging probes or enrichment tags. In this review, we first give a brief introduction on the history and current progress of MGL and bioorthogonal chemistry. Secondly, we discuss the application of MGL in the studies of dynamic changes and regulation of sialylation in various biological processes. Several examples from our research group on the studies of sialylation dynamics in epithelial-mesenchymal transition (EMT), neuronal stem cell differentiation, and cardiac hypertrophy are presented. By metabolic labeling of sialoglycans with ManNAz during EMT, we observed that cellular sialylation was downregulated during EMT, followed by reversion and upregulation. In neuronal stem cells, metabolic labeling of cell-surface sialoglycans has been exploited to discover cell-surface markers. Sialylation in cardiac hypertrophy was investigated by MGL in intact rat hearts, which revealed upregulation of sialylation during hypertrophy. Thirdly, aiming to expand the applications of MGL, we have developed new methods for protein-specific glycan imaging, cell- and tissue-selective glycan labeling, glycan Raman imaging, and novel unnatural sugars. By combining MGL with site-specific protein labeling, we developed a cis-membrane FRET-based methodology to visualize glycans of specific proteins of interest on live cells. Using the protein-specific glycan imaging technique, we found that sialylation of α X β 2 integrin is important for its activation. To overcome the limitation that MGL lacks cell-type selectivity, we developed the liposome-assisted bioorthogonal reporter (LABOR) strategy, in which azido sialic acid is encapsulated in ligand-targeted liposomes for cell-selective labeling of sialylated glycans via the receptor-mediated endocytosis. We demonstrated the LABOR strategy by selective labeling of sialoglycans in folate receptor-overexpressed cells. LABOR enables targeted imaging of tumor-associated sialoglycans and brain sialoglycans in living mice. Fourthly, novel unnatural sialic acids have been developed for probing specific sialoglycoforms, identifying sialic acid-binding proteins, remodeling cell-surface sialic acid, and bioorthogonal Raman imaging of sialylated glycans. Finally, we give an outlook on future directions of studying sialobiology using these chemical methods.

Cell-Selective Metabolic Glycan Labeling Based on Ligand-Targeted Liposomes

Imaging of protein-specific glycosylation by glycan metabolic tagging and in situ proximity ligation.

Liposome-Assisted Metabolic Glycan Labeling With Cell and Tissue Selectivity.

Mechanistic Investigation and Multiplexing of Liposome-Assisted Metabolic Glycan Labeling

A Photocaged Azidosugar for Light‐Controlled Metabolic Labeling of Cell‐Surface Sialoglycans

A nongenetically encoded and erasable imaging strategy for receptor-specific glycans on live cells.

Nanopipette-assisted Single Cell Metabolic Glycan Labeling

Targeted Imaging and Proteomic Analysis of Tumor‐Associated Glycans in Living Animals

Metabolic Labeling and Targeted Modulation of Adipocytes

Chemical Labeling and Analysis of Sialoglycans

Cell-selective Metabolic Labeling of Biomolecules with Bioorthogonal Functionalities

A Cis-Membrane FRET-based Method for Protein-Specific Imaging of Cell-Surface Glycans.

Dual-Responsive Metabolic Precursor and Light-Up AIEgen for Cancer Cell Bio-orthogonal Labeling and Precise Ablation.

Organelle-Directed Metabolic Glycan Labeling And Optical Tracking Of Dysfunctional Lysosomes Thereof

Selective in vivo metabolic cell-labeling-mediated cancer targeting

Bifunctional Unnatural Sialic Acids for Dual Metabolic Labeling of Cell-Surface Sialylated Glycans.

Facile Click-Mediated Cell Imaging Strategy of Liposomal Azido Mannosamine Lipids Via Metabolic or Nonmetabolic Glycoengineering

Bioorthogonal Chemical Labeling Probes Targeting Sialic Acid Isomers for N-Glycan MALDI Imaging Mass Spectrometry of Tissues, Cells, and Biofluids

Labeling Cell Surface GPIs and GPI-Anchored Proteins Through Metabolic Engineering with Artificial Inositol Derivatives.

Azido-galactose outperforms azido-mannose for metabolic labeling and targeting of hepatocellular carcinoma.

Metabolic Glycan Labeling-Assisted Discovery of Cell-Surface Markers for Primary Neural Stem and Progenitor Cells.